Forever Labs Patents

Patent portfolio assigned to Forever Labs (verified via public assignee records). Adult mesenchymal stem-cell banking (B2C); no named business customers. Closest competitors are cord-blood / stem-cell banks. Patents confirmed under assignee Forever Labs, Inc. on Justia (extracellular-vesicle isolation, dynamic incubator systems); exact count not verified.